Report: Traditional Drug Selling Is Becoming 'Obsolete'Read the rest of this entry »
The future of pharmaceutical sales marketing will look very different in the next decade from what it was in the last. These changes, which began to take shape even before the start of the Great Recession, are accelerating, leading, says a PricewaterhouseCoopers report, "to a new marketing and sales system with a smaller, more agile and smarter sales force."
Among the headwinds that are forcing drug makers to change tactics ...
Value-Based Drug Pricing Is Gaining More AttentionRead the rest of this entry »
In the face of blistering criticism over drug pricing from Republicans and Democrats alike, pharmaceutical firms are experimenting with "value-based" pricing.
The concept is not especially new; over the years, academics and healthcare reformists have proposed it as one model for overhauling how medicine is practiced in the U.S. Implementing it as a pricing model for drugs is relatively new.
As a PwC whitepaper last month explains, a value-based ...
Pharma Turns to Social Media to Recruit VolunteersRead the rest of this entry »
Recruiting participants for clinical trials can be as much of a challenge as hiring experienced workers for skilled jobs. A stunningly high percentage of trials never get underway because enough patients can't be recruited. And attrition rates average 30%, causing some trials to have to shut down.
For years, drug companies have resorted to advertising their need for volunteers on radio, in print, on TV. Lately, they have ...
Pharm Deals Topped $189 Billion In 2016Read the rest of this entry »
The pharmaceutical and biotech industry saw a total of 2,028 deals made in 2016, with an aggregate deal value of $189 billion, according to a recently released factbook by Research and Markets.
Summarizing the broad findings, Research and Markets says, "Pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market such as increasing costs of production and R&D, shifts in patent laws, and challenges ...
Pharma and Biotech Often Turn to Search Firms For HelpRead the rest of this entry »
When companies need specialized talent or are having a hard time filling in-demand jobs, they often turn to executive search firms like Green Key Resources for help. While all industries use search firms, companies in sectors where the specialized talent is especially limited and highly sought after are the ones most often engaging search firm help.
A just released report says pharmaceutical and biotechnology companies regularly call on search firms ...
Pharma Striking Early Stage Deals With AcademiaWith the price of developing a new drug and bringing it to market running into the hundreds of millions and up to more than $2.5 billion, pharmaceutical companies are forging partnerships with universities to help cut the cost and hasten the process.Read the rest of this entry »
Academic researchers and major drug companies have worked together in the past, typically at the clinical trial stage. Now, big pharma is looking to partner with universities ...
Report Shows Workforce Drug Use Increased In 20164.2% of American workers tested positive for drugs last year, the highest rate in a dozen years, according to Quest Diagnostics.Read the rest of this entry »
The company, one of the largest providers of medical and diagnostic tests in the U.S., issued its annual Quest Diagnostics Drug Testing Index in May. The company said it found cocaine, marijuana and methamphetamine use was up across the nation.
“This year’s findings are remarkable because ...
The Highest Paying Life Sciences Job You Never Heard OfWhat's the highest paying job in biotech you've probably never heard of?Read the rest of this entry »
OK. That's sort of a trick kind of question, since you can't really answer it if you've never heard of it. So we'll tell you what BioSpace said the job is: Medical Science Liaison.
The site, which describes itself as a "digital hub for news and careers" in life sciences, said the ...
3D Printers Are Pharma's 'Next Great Step'3D printing came to the pharmaceutical industry two years ago when the FDA gave Aprecia Pharmaceuticals approval to use the technology to manufacture its epilepsy medication Spritam.Read the rest of this entry »
Though adoption of 3D pharmaceutical manufacturing is in its infancy, within a decade the medical application of the technology could exceed $1.9 billion, an estimate that may already be outdated as the pace of development has been accelerating steadily. Before drug companies ...
How the Pharmaceutical Industry May Track Every PillA technology most commonly linked to the cryptocurrency payment system Bitcoin, may prove to be the key to rooting out counterfeit prescription drugs.Read the rest of this entry »
Blockchain startup Chronicled and supply chain consultant, The LinkLab, last week announced a pilot "track and trace" program for the pharmaceutical industry.
The industry is under a 2023 deadline to develop and implement an electronic, interoperable system to identify and trace prescription drugs throughout the U.S ...